Search

Your search keyword '"Ricardo Zamel"' showing total 64 results

Search Constraints

Start Over You searched for: Author "Ricardo Zamel" Remove constraint Author: "Ricardo Zamel"
64 results on '"Ricardo Zamel"'

Search Results

1. Ischemia-Reperfusion Injury in a Simulated Lung Transplant Setting Differentially Regulates Transcriptomic Profiles between Human Lung Endothelial and Epithelial Cells

2. Metabolomic heterogeneity of pulmonary arterial hypertension.

3. PKC activation induces inflammatory response and cell death in human bronchial epithelial cells.

4. Variation at DENND1B and Asthma on the Island of Tristan da Cunha

5. Use of metabolomics to identify strategies to improve and prolong ex vivo lung perfusion for lung transplants

6. Eosinophils in transbronchial biopsies: a predictor of chronic lung allograft dysfunction and reduced survival after lung transplantation - a retrospective single-center cohort study

7. Ischemia-reperfusion induces death receptor-independent necroptosis via calpain-STAT3 activation in a lung transplant setting

8. Strategies to prolong homeostasis of ex vivo perfused lungs

9. Higher M30 and high mobility group box 1 protein levels in ex vivo lung perfusate are associated with primary graft dysfunction after human lung transplantation

10. Potential therapeutic targets for lung repair during human

11. Bronchoalveolar bile acid and inflammatory markers to identify high-risk lung transplant recipients with reflux and microaspiration

12. Variation at

13. Circulating Cell Death Biomarkers May Predict Survival in Human Lung Transplantation

14. Transcriptomic investigation reveals donor-specific gene signatures in human lung transplants

15. Potential therapeutic targets for lung repair during human ex vivo lung perfusion

16. Neutrophil extracellular traps in

17. Normothermic ex vivo lung perfusion: Does the indication impact organ utilization and patient outcomes after transplantation?

18. Effects of Nissen Fundoplication on Markers of Microaspiration and Inflammation after Lung Transplantation

19. Lung Bile Acid as Biomarker of Microaspiration and Its Relationship to Lung Inflammation

20. XB130 promotes bronchioalveolar stem cell and Club cell proliferation in airway epithelial repair and regeneration

21. The role of the endothelin-1 pathway as a biomarker for donor lung assessment in clinical ex vivo lung perfusion

22. Protein Expression Profiling Predicts Graft Performance in Clinical Ex Vivo Lung Perfusion

23. Towards donor lung recovery-gene expression changes during ex vivo lung perfusion of human lungs

24. Distinct Expression Patterns of Alveolar 'Alarmins' in Subtypes of Chronic Lung Allograft Dysfunction

25. Elevated CXCL10 (IP-10) in Bronchoalveolar Lavage Fluid Is Associated With Acute Cellular Rejection After Human Lung Transplantation

26. Feasibility of Avoiding Higher Risk Epitope and Allele HLA Mismatch to Reduce de novo Donor Specific Antibody (dnDSA) in Lung Transplantation

27. Metabolic Profile of Ex Vivo Lung Perfusate Yields Biomarkers for Lung Transplant Outcomes

28. Emergence of a Specific Intrapulmonary CD4+ T Cell Subset Prior to the Onset of Lung Allograft Dysfunction

29. Neutrophil extracellular traps in ex vivo lung perfusion perfusate predict the clinical outcome of lung transplant recipients

30. Ribonucleic Acid Microarray Analysis From Lymph Node Samples Obtained by Endobronchial Ultrasonography-Guided Transbronchial Needle Aspiration

31. Soluble Adhesion Molecules During Ex Vivo Lung Perfusion Are Associated With Posttransplant Primary Graft Dysfunction

32. Eosinophils on Transbronchial Biopsies Are Predictive of Reduced Survival After Lung Transplantation

33. Untreated Subclinical Minimal Acute Rejection Does Not Increase the Risk for Chronic Lung Allograft Dysfunction and Death After Lung Transplantation

34. Differential Gene Expression Profiling of Reperfusion During Ex Vivo Lung Perfusion and Lung Transplantation in Humans

35. Fractal circuit sensors enable rapid quantification of biomarkers for donor lung assessment for transplantation

36. Importance of left atrial pressure during ex vivo lung perfusion

37. Potential role of CC chemokine receptor 6 in prediction of late-onset cytomegalovirus infection following solid organ transplant

38. Cell-Free DNA in Human Ex-Vivo Lung Perfusate as a Potential Biomarker to Predict the Risk of Primary Graft Dysfunction (PGD) in Lung Transplantation

39. Metabolomic heterogeneity of pulmonary arterial hypertension

40. Towards Donor Lung Recovery - Gene Expression Changes During Ex Vivo Lung Perfusion

41. PKC activation induces inflammatory response and cell death in human bronchial epithelial cells

42. Okadaic acid-induced actin assembly in neutrophils: Role of protein phosphatases

43. Circulating Adhesion Molecule in Ex-Vivo Lung Perfusion Predicts Primary Graft Dysfunction

44. A Positive Left Atrial Pressure Is Important During Ex Vivo Lung Perfusion

45. Metabolic Profiling of Perfusate from Clinical Ex Vivo Lung Perfusion Yields Potential Biomarkers of Early Lung Transplant Outcomes

46. The Impact of Cell Death Signals on Short and Long Term Outcome in Human Lung Transplantation

47. Ex-Vivo Lung Perfusate Cell Death Markers May Predict Long Term Outcomes After Transplantation

48. Discovery of mRNA Biomarkers Predicting Donor Lung Failure

49. Metabolites in Human Ex Vivo Lung Perfusates Are Differentially Affected in Brain Death (BDD) vs. Cardiac Death Donors (DCD) and Modified by Duration of Normothermic Perfusion

50. Exceptionally fast self-cleavage by a Neurospora Varkud satellite ribozyme

Catalog

Books, media, physical & digital resources